Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 November 2018

November 16, 2018 – EMA’s human medicines committee (CHMP) recommended four medicines for approval, including a medicine for use in countries outside the European Union, at its November 2018 meeting. Four recommendations on extensions of therapeutic indication.
Positive recommendations on extension of therapeutic indication following re-examination.
Withdrawal of extension of indication application.
Leggi tutto